Vo preostanatite redovi do-daden e samo etanol. Po uparuvanje na istiot preku nokj (ON), nasobna temperatura, bunarchinjata se blokirani so 1% BSA/PBS, 2 chna 4oC. Po mienje so 0,1% BSA/PBS, vo duplikat se dodadeni se-rumite (od 1:200 do 1:6400) i inkubirani ON na 4oC. Po mienje (0.1%Tween 20 / 0,1% BSA/PBS) dodaden e peroksidaza konjugiran anti-khuman IgG (1:1000) i plochite se inkubirani 2 ch na 4oC. Po mienje bo-jata e razviena so dodavanje na substraten rastvor (0.25 mg/mlo-fenilen diamin) i 30% H2O2. Po 20 min reaktsijata e stopiranaso 3M H2SO4 i absorbantsijata e izmerena na 490 nm. Kako kontro-la za optimalnoto oblozhuvanje na bunarchinjata koristen e kolera319fIfth congress of pharmacy of macedonIa WIth InternatIonal partIcIpatIonMacedonian Pharmaceutical Bulletin 57 (suppl), 2011CLINICAL PHARMACY oral presentationstoksin kako spetsifichen marker za GM1.Za da se opredeli anti-GM1 reaktivnosta koristena e srednatavrednost od razlikata na optichkite gustini (d-OD) od dve bunarchi-nja oblozheni so GM1 i dve neoblozheni. Za da se opredelat cut-offvrednostite za pozitivnata IgM i IgG anti-GM1 reaktivnost, kon-struirana e ROC kriva so pomosh na statistichkiot softver Med-Calc(r). ROC-krivite se konstruirani vrz osnova na dobienite d-ODod 24 patsienti so MMN za IgM i 24 patsienti so GBS za IgG, bidejkiovie subgrupi na patsienti pokazhuvaat relativno najvisoka i naj-chesta reaktivnost za soodvetnite izotipovite vo literaturata ivo nashite dosegashni istrazhuvanja [9]. Vo ROC-krivite, rezultatiteod d-OD od 24 zdravi dariteli se koristeni kako kontrolna grupaza dvata izotipa.REzUlTATI I DISKUSIJAOptimizatsija na metodotPri optimizatsija na ELISA postapkata za opredeluvanje na anti-GAb analizirani se nekolku faktori. Glavniot problem vo posto-echkiot protokol beshe visokata vrednost na pozadinskata absor-btsija na bunarchinjata bez antigen, koja interferirashe so spetsi-fichnosta i osetlivosta na antitelata.Vo ispituvanjata koristeni se mikrotitarski plochi so bunarchinjaso ramno dno i visok afinitet. Kako rastvoruvach za oblozhuvanjeizbran e absoluten etanol bidejki istiot e najchesto koristen voliteraturnite podatotsi i dava reprodutsibilni rezultati vo nashi-te ispituvanja.Optimalnata kontsentratsija na GM1 i dilutsijata na sekundarnotoantitelo e opredelena so titratsija i iznesuva 0,2 ug/100ul na bu-narche za GM1 i razreduvanje od 1:1000 za sekundarnoto antitelo.Od rastvorot za blokiranje (BSA-PBS) ispituvani se razlichni kon-tsentratsii pri shto za optimalna e opredelna kontsentratsijata od10 g/L.Vo chekorot na mienje na primarnoto antitelo utvrdeno deka 0,1%rastvor na Tween 20 vo 0,1% BSA/PBS optimalno ja namaluva poza-dinskata absorptsija.Opredeluvanje na cut-off vrednostiSo ROC analizata opredeleni se cut-off vrednostite za pozitivnaIgG i IgM anti-GM1 reaktivnost. Kako negativni, koristeni serezultatite od d-OD od HC a kako pozitivni rezultatite od d-ODza IgM i IgG dobieni od patsienti so MMN i GBS, soodvetno (Slika1). ROC analizata ukazha na spetsifichnost od 100% za IgM i 100% zaIgG so osetlivost od 46% i 21%, soodvetno. Povrshinata pod ROCkrivata iznesuva 0,78 za IgM i 0,67 za IgG.Slika 1. ROC krivi za anti-GM1 reaktivnostOptimalnata cut-off vrednost dobiena od ROC analizata e 0,3 zaIgM i 0,2 za IgG. Poniski vrednosti ja zgolemuvaat osetlivosta norezultiraat so povisoka greshno pozitivna fraktsija. Za ovoj testse preporachuva pomala greshno pozitivna fraktsija za smetka napovisoka senzitivnost.zAKlUChOKOptimiziran e ELISA metod za opredeluvanje na serumski anti-GM1antitela koj mozhe da se koristi vo dijagnoza na imunoposreduvaniperiferni nevropatii.REFERENTsI[1] Adams D, Kuntzer T, Burger D, Choffon M, Magistris MR, Regli F, Steck AJ J Neu-roimmunol 1991; 32:223-230[2] Sadiq SA, Thomas FP, Kilidireas K, Protopsaltis S, Hays AP, Lee KW, et al. Neurol-ogy 1990;40:1067-72. [3] Berg LH, Marrink AEJ, Jong HJ, Imhoff GW, Latov N, Sadiq SA. J Nerurol NeurosurgPsych 1992;55:8-11. [4] Willison HJ, Yuki N. Brain 2002;125:2591- 625. [5] Feldman EL, Bromberg MB, Alberes JW, Pestronk A. Ann Neurol 1991;30:397-401. [6] Alaedini A, Latov N. J Clin Lab Anal 2001;15:96-9[7] Conrad K, Schneider H, Ziemsen T, Talaska T, Reinhold D, Humbel RL, RoggenbuckD. Ann NY Acad Sci, 1109: 256-64[8] Ravindranath MH, Ravindranath RM, Morton DL, Graves MC 1994, J immunol Meth-ods. 1994; 169: 257-72[9] Kuijf M, van Doorn P, Tio-Gillen A, Geleijns K, Ang W Hooijkaas H, Hop W.Jacobs.2005; J Neurol Sci, 239; 37 - 44[10] Bech E, Jakobsen J, Orntoft T, Clin Chem 1994: 40/7, 1331-4characterIzatIon of glycoproteInsIsolated from human perIpheralnerve and tWo campylobacterjejunI o:19 Isolates: enterItIsand gbs assocIatedK. Brezovska1, A. Poceva Panovska1, A. Grozdanova1,S. Apostolski2, Lj. Suturkova11 Faculty of Pharmacy, University Ss. Cyril and Methodius, Skopje,Macedonia2 Outpatient Neurological Clinic, Belgrade, SerbiaIntroductIonAntibodies that cross-react with lipopolysaccharide (LPS) from Campy-lobacter jejuni (C.jejuni) and with different gangliosides from peripheralnerves are detected in sera from patients with Guillain-Barre (GBS) fol-lowing infection with C.jejuni [1]. The response to bacterial and neu-ral glycolipids is significantly lower in patients with uncomplicatedC.jejuni enteritis, despite the presence of ganglioside mimics in theLPS of some enteritis isolates. These findings underscore the influ-ence of other host related factors in addition to bacterium relatedfactors, in the development of neurological symptoms after an infec-tion with C.jejuni [2]. Sera from patients with GBS following infectionwith C.jejuni, showed positive reactivity to a 63 kDa flagellar proteinpurified from C.jejuni (O:19) and with Gal (b1-3) GalNAc - bearingglycoproteins isolated from peripheral nerve [3,4]. These data indicateon possible molecular mimicry of glycoproteins present in C.jejuni andGal (b1-3) GalNAc - bearing glycoproteins present in human peripheralnerve and its potential role in the development of neuropathies.The aim of our study was to characterize the glycoproteins present inhuman peripheral nerve and in C.jejuni (O:19) isolated from patientwith uncomplicated enteritis and C.jejuni (O:19) isolated from patient320PETTI KONGRES NA FARMATsIJATA SO MEGjUNARODNO UChESTVOMakedonski farmatsevtski bilten 57 (dodatok), 2011KLINIChKA FARMATsIJA oralni prezentatsiiwith enteritis followed by GBS. For that purpose we tested the reac-tivity of total protein extracts from human peripheral nerve and fromtwo bacterial isolates with peanut agglutinin (PNA) as a marker for theGal (b13) GalNAc determinant and with sera from patients with GBS.experImentalIsolation of glycoproteins from human peripheral nerveHuman peripheral nerve was obtained at postmortem within 8 hr afterdeath from patients who died from non-neurological disease and waskept frozen at -70 degC (Department of forensic medicine, Faculty ofMedicine, University Ss. Cyril and Methodius, Skopje, Macedonia). Iso-lation of glycoproteins from human peripheral nerve was done ac-cording to Apostolski et al., 1994 [4]. Obtained isolate was stored at20degC, until use.Isolation of proteins from C. jejuni serotype O:19 (GBS and enteritis as-sociated)C. jejuni serotype O:19, GBS associated, was obtained from ATCC700297. C.jejuni serotype O:19, enteritis associated, was obtainedfrom the Institute for Microbiology and Parasitology, Faculty of Med-icine, Skopje. Cultures were grown at 37deg in Campylobacter agar, 48 hunder microaerophilic conditions. Proteins were extracted from thebacterial cells using the method described by Liu X, et al., 2006 [5].Determination of protein concentrationThe protein concentration (mg/ml) in the isolates were determinedusing Bradford microassay procedure, using the calibration curve (ab-sorbance relative to the concentration) obtained from standard solu-tions of bovine serum albumin (BSA) in concentration range 0.2 - 3mg/ml [6].Western blot analysis of isolated glycoproteinsIsolated glycoproteins (10 mg/well) were separated on 10 % acry-lamid/bisacrylamid gel, using sodium dodecyl sulphate-polyacrylamidegel electrophoresis according to the method of Laemmli 1970 [7].After electrophoresis proteins were transferred onto nitrocellulosesheets and analyzed on western blot by incubating with biotinylatedPNA (10 mg/ml) and sera from 6 patients with GBS (1:100).results and dIscussIonThe concentrations of isolated glycoproteins from human peripheralnerve and from C.jejuni (O:19), enteritis associated and GBS associ-ated, determined by the method of Bradford are given in Table 1.Table 1. Concentration of the protein isolatesPNA staining of the separated glycoproteins isolated from humanperipheral nerve and C.jejuni (O:19) indicate on the presence of theGalGalNAc determinant in several proteins (Fig 1).Fig 1. Western blot of isolated glycoproteins from: human peripheralnerve (Lane 1), C.jejuni GBS associated (Lane 2), C.jejuni enteritis as-sociated (Lane 3) stained with biotinylated PNA.Western blot analysis of the reactivity of isolated proteins to sera frompatients with GBS, revealed positive reactivity of one main proteinband with mobility of approximately 60 kDa, present in all three pro-tein extracts (Fig 2). Figure 2 also shows positive reactivity of bandswith molecular weight lower than 60 kDa. The reactive bands weremore intense in lanes with isolate from C.jejuni (O:19) GBS associated.Fig 2. Western blot of isolated glycoproteins from: human peripheralnerve (Lane 1), C.jejuni GBS associated (Lane 2) and C.jejuni enteritisassociated (Lane 3) incubated with GBS sera.conclusIonThe presence of the GalGalNAc determinant was confirmed in severalglycoproteins present in protein extracts from human peripheral nerveand from two bacterial isolates: C.jejuni O:19 enteritis associated andGBS associated. These glycoproteins showed cross-reactivity to serafrom patients with GBS, which supports the hypothesis of molecularmimicry between human and bacterial glycoprotein structures. Fur-ther studies are needed for elucidation of the molecular structure ofthe cross-reactive glycoproteins and their potentional role in patho-genesis of autoimmune neuropathies.referencesWirguin I, Suturkova-Milosevic Lj, Della-Latta P, Fisher T, Brown RH Jr, Latov N (1994),Ann. Neurol., 35: 698-7032.Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Vanden Braak N, Jacobs BC, Van Doorn PA (2002), Infect. Immun., 70: 1202-12083.Lange D, Aleksic S, Kassubek J, Vrvic MM, Kist M, Steinbruckner B, Mitova M (1999),Zent. Bl. Bakteriol., 289: 429-4444. Apostolski S, Sadiq SA, Hays A, Corbo M, Suturkova-Mislosevic Lj, Chaliff P, Ste-fansson K, LeBaron RG, Ruoslahti E, Hays AP, Latov N. (1994) J Neurosci Res; 38:134-1415. Liu X, McNally DJ, Nothaft H, Szymanski CM, Brisson JR, Li J. (2006) Anal. Chem. ; 78:6081-6087.6. Bradford M.M. (1976) Anal.Biochem., 72, 148-2547. Laemmli (1970) U.K. Nature, 227: 680-685321fIfth congress of pharmacy of macedonIa WIth InternatIonal partIcIpatIonMacedonian Pharmaceutical Bulletin 57 (suppl), 2011CLINICAL PHARMACY oral presentationsKARAKTERIzATsIJA NA GlIKOPROTEINIIzOlIRANI OD khUMAN PERIFERENNERV I OD DVA IzOlATINA campylobacter jejunI (o:19):ENTERITIS I gbs ASOTsIRANIK.Brezovska1, A.Potseva Panovska1, A.Grozdanova1,S.Apostolski2, Lj.Shuturkova11 Farmatsevtski fakultet, Univerzitet ,,Sv. Kiril i Metodij",Skopje, R. Makedonija2 Ordinatsija za nevrologija "Dr. Apostolski", Belgrad, SrbijaVOVEDVo serumi od patsienti so Guillain-Barre sindrom (GBS), nastanat poinfektsija so Campylobacter jejuni (C.jejuni), se detektirani anti-tela koi vkrsteno reagiraat so lipopolisakharidot (LPS) od C.je-juni i so razlichni gangliozidi od perifernite nervi [1]. Imu-noloshkiot odgovor kon bakteriskite i nevralnite glikolipidi eznachitelno ponizok kaj patsienti so nekomplitsirana infektsija soC.jejuni i pokraj prisustvoto na gangliozidna mimikrija vo izoli-raniot LPS.